Nanoparticle-laden contact lens for controlled ocular delivery of prednisolone : formulation optimization using statistical experimental design by ElShaer, Amr et al.
pharmaceutics
Article
Nanoparticle-Laden Contact Lens for Controlled
Ocular Delivery of Prednisolone: Formulation
Optimization Using Statistical Experimental Design
Amr ElShaer 1,*, Shelan Mustafa 1, Mohamad Kasar 1,†, Sapana Thapa 1,†, Baljit Ghatora 1
and Raid G. Alany 1,2
1 Drug Discovery, Delivery and Patient Care (DDDPC), School of Life Sciences, Pharmacy and Chemistry,
Kingston University London, Kingston upon Thames KT1 2EE, UK; k0846770@kingston.ac.uk (S.M.);
d-kasar@hotmail.com (M.K.); k1104689@kingston.ac.uk (S.T.); B.Ghatora@kingston.ac.uk (B.G.);
R.Alany@kingston.ac.uk (R.G.A.)
2 School of Pharmacy, The University of Auckland, Auckland 1142, New Zealand
* Correspondence: a.elshaer@kingston.ac.uk; Tel.: +44-0-20-8417-7416
† These authors contributed equally to this work.
Academic Editor: Afzal R. Mohammed
Received: 18 January 2016; Accepted: 1 April 2016; Published: 20 April 2016
Abstract: Human eye is one of the most accessible organs in the body, nonetheless, its physiology
and associated precorneal factors such as nasolacrimal drainage, blinking, tear film, tear turnover,
and induced lacrimation has significantly decreased the residence time of any foreign substances
including pharmaceutical dosage forms. Soft contact lenses are promising delivery devices that
can sustain the drug release and prolong residence time by acting as a geometric barrier to drug
diffusion to tear fluid. This study investigates experimental parameters such as composition of
polymer mixtures, stabilizer and the amount of active pharmaceutical ingredient on the preparation
of a polymeric drug delivery system for the topical ocular administration of Prednisolone. To achieve
this goal, prednisolone-loaded poly (lactic-co-glycolic acid) (PLGA) nanoparticles were prepared
by single emulsion solvent evaporation method. Prednisolone was quantified using a validated
high performance liquid chromatography (HPLC) method. Nanoparticle size was mostly affected
by the amount of co-polymer (PLGA) used whereas drug load was mostly affected by amount
of prednisolone (API) used. Longer homogenization time along with higher amount of API
yielded the smallest size nanoparticles. The nanoparticles prepared had an average particle size of
347.1 ˘ 11.9 nm with a polydispersity index of 0.081. The nanoparticles were then incorporated in the
contact lens mixture before preparing them. Clear and transparent contact lenses were successfully
prepared. When the nanoparticle (NP)-loaded contact lenses were compared with control contact
lenses (unloaded NP contact lenses), a decrease in hydration by 2% (31.2% ˘ 1.25% hydration for the
0.2 g loaded NP contact lenses) and light transmission by 8% (unloaded NP contact lenses 94.5% NP
0.2 g incorporated contact lenses 86.23%). The wettability of the contact lenses remained within the
desired value (<90 ˝C) even upon incorporation of the NP. NP alone and NP-loaded contact lenses
both displayed a slow in vitro drug release of drug over 24 h; where 42.3% and 10.8% prednisolone
release were achieved, respectively. Contact lenses can be used as a medicated device to sustain ocular
drug delivery and improve patient compliance; nonetheless, patients and healthcare professionals’
acceptability and perceptions of the new formulations entail further investigations.
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1. Introduction
Although the eye is one of the most accessible organs in human body, its physiology has made it
quite impermeable to foreign substances. These characteristics protect the delicate structure of the eye
from many harmful substances [1]. On the other hand, it has also proven to be a great challenge for
ocular drug delivery purposes. Many approaches and strategies have been adopted to come up with
an efficient delivery system to the eyes.
The most common dosage forms used for ocular drug delivery are eye drops, ointments, gels,
or emulsions; they are mostly used to treat ocular surface and anterior segment diseases. It is the
most preferred method due to the ease of drug administration and low cost. The site of action for
most topically applied ophthalmic drugs is the cornea, conjunctiva, sclera, and the other tissues of the
anterior segment such as the iris and ciliary body (anterior uvea). Following topical administration,
several factors negatively affect the bioavailability of such formulations; these factors are known as
precorneal factors and include nasolacrimal drainage, blinking, tear film, tear turnover, and induced
lacrimation [2]. These factors cause the contact time to be drastically decreased, which is the primary
reason why only 5% or even less of the applied dose reaches the intraocular tissues [3]. Hence,
formulation scientists became interested in new alternatives for conventional ocular delivery systems.
Ocular films, inserts and soft contact lenses were investigated, and some of them have managed to
reach the market such as Ocusert® and Lacrisert®.
Soft contact lenses are promising delivery devices that can sustain the drug release and prolong
residence time by acting as a geometric barrier to drug diffusion to tear fluid. Besides, medicated
contact lenses have a potential market as they are in use by more than 125 million people around the
globe [3]. The possibility of using contact lenses for ocular drug delivery was first discussed by Sedlacek
in the mid-1960s. Soaking a pre-prepared contact lens was employed for drug loading in early studies
with loading efficiency between 0.01 and 5.53 mg/lens [4]. Despite improving drug residence time,
pre-soaked contact lenses failed to load sufficiently high quantities of therapeutic agents and failed
to sustain the drug release. Nanoparticle-laden soft contact lenses were explored as nano-reservoirs
to extend the drug supply across the eye. The study conducted by Jung and Chauhan, evaluated the
release of timolol from nanoparticle-laden contact lenses. Ethylene glycol dimethacrylate (EGDMA)
and propoxylated glyceryl triacylate (PGT) monomers were used to prepare the nanoparticles of
3.5 nm diameter. Around 48%–66% of timolol was loaded within the nanoparticulate systems and
its release was sustained for 24–48 h in diffusion cells at a therapeutic dose without compromising
the transparency of the contact lens [5]. A second study conducted by Fazly et al., 2013 assessed the
antimicrobial effects of silver nanoparticles loaded in contact lenses on Pseudomonas aeruginosa and
Staphylococcus aureus over 72 h. Contact lenses with relatively high doses of 57.13 and 98.06 µg of silver
nanoparticles managed to inhibit the growth of the pathogenic bacteria for 48 and 72 h [6].
There are several methods used to produce PLGA nanoparticles, the most common technique
being emulsification-solvent evaporation. The method used to prepare the PLGA nanoparticles is likely
to have an effect on the microstructure formed; one could end up with nanocapsules in which the drug
is trapped inside the core or nanospheres where the drug is adsorbed at the surface. Furthermore, the
drug release mechanism and in vivo performance of nanoparticle has been shown to be dependent on
the polymer used and on the loading efficiency. This was demonstrated in a study by Fadel et al. (2010)
where zinc (II) phthalocyanine (ZnPc) was encapsulated in PLGA nanoparticles and was compared
to free ZnPc. The results showed that the encapsulated ZnPc resulted in considerably smaller tumor
size than the free ZnPc indicating a successful drug delivery [7,8]. Moreover, Gupta et al. (2010)
developed and characterized PLGA nanoparticles to load sparfloxacin for sustained delivery [9]. The
drug-loaded nanoparticles were prepared using a precipitation method with different drug-to-polymer
ratios. The size of the formed particles ranged between 180 and 190 nm and the zeta potential was
´22 mV. The prepared batches with different drug-to-polymer ratio showed drug entrapment ranging
from about 25% to 86%. Compared with the marketed formulation which released over 96% of the drug
within 6 h, the PLGA nanoparticles sustained the drug release with about 85.8% release over 24 h [9].
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Aksungur et al. (2011) formulated nanoparticles (NP) using PLGA and loaded cyclosporine A
(CsA) [10]. NP were prepared using PLGA alone or in mixture with Eudragit®RL (positively
charged polymer) or coated with Carbopol® (hydrophilic, negatively charged and mucoadhesive).
NP was formed using the oil in water emulsification method. High entrapment efficacy
(91.3%) was demonstrated by PLGA nanoparticles (NP) loaded with CsA (93.4%) and also with
a PLGA-Eudragit®RL mixture. These entrapment efficiency values were attributed to the lipophilic
nature of CsA, which resulted in good solubility in the oil phase, thus preventing loss via the aqueous
phase. The average particle size ranged between 148 and 219 nm for the Eudragit®RL-coated NP,
whereas Carbopol®-coated NP had slightly larger particle size (393 nm). The drug release profile
showed an initial burst release followed by slower release. The total drug released over 24 h was
between 75% and 90% [10].
Prednisolone is a synthetic glucocorticoid derived from cortisol. Prednisolone acetate or sodium
phosphate are used as ophthalmic suspensions in eye drops to reduce allergic reactions affecting the
eye and to relieve the accompanying symptoms such as redness, swelling and itching of the eye; it was
used in the current study as a model drug [11,12].
The main aim of this research is to investigate (using statistical experimental design) the
parameters that will affect the formulation of PLGA nanoparticles for the ocular delivery of
prednisolone. It is envisaged that the formed nanoparticles will be integrated into a soft contact
lens to promote extended prednisolone release, hence improving ocular bioavailability.
2. Materials and Methods
2.1. Materials
Prednisolone (purity >98%, MW 360.45) was purchased from Tokyo Chemical Industry (TCI) Co.
Ltd., Tokyo, Japan. Poly DL-lactic-co-glycolic acid (PLGA) (lactide: glycolide (65:35), MW 44,000–75,000)
and polyvinyl alcohol (PVA; hydrolyzed 98%–99%) all were purchased from Aldrich Chemistry
(Sigma-Aldrich) St. Louis, MO, USA. Dichloromethane (DCM), stabilized with 0.2% of ethanol was
purchased from VWR Chemicals Hunter Boulevard, Leicestershire, UK. Sodium chloride (NaCl)
provided from Fisher Scientific, Loughborough, UK (laboratory reagent grade, MW: 58.44); Sodium
hydrogen carbonate (NaHCO3; laboratory reagent grade, MW: 84.01) provided from Fisher Scientific,
Loughborough, UK; calcium chloride dehydrate (CaCl¨ 2H2O; for molecular biology ě99%, MW:
147.01) provided from Sigma Aldrich, Dorset, UK; Potassium chloride (KCl; ReagentPlusTM ě99%,
MW: 74.55) provided from Sigma Aldrich, Dorset, UK.
2.2. Prednisolone Quantification
Prednisolone was separated and quantified by liquid chromatographic analysis using (Shimadzu
LC-2010A HT, Columbia, MD, USA) HPLC system. The separation was achieved through the use of
Beckman Coulter Ultrasphere ODS column, Pasadena, CA, USA (5 µm, 4.6 mm ˆ 25 cm). The mobile
phase was composed of 60% methanol and 40% distilled water v/v and was pumped at a flow rate of
1 mL/min and an injection volume of 10 µL. Prednisolone had a retention time of 3.675 ˘ 0.007 min
when analyzed at λmax of 254 nm. The validation of the method was carried out in accordance with the
International Conference of Harmonization (ICH) guidelines. For the detection limit, the calibration
curve was established at a concentration range of 1–1000 µm with coefficient of variation (r2 = 0.999).
2.3. Design of Experiment (DoE)
Minitab Design of Experiment (DoE) software was used to investigate the variables affecting the
preparation of PLGA nanoparticles. The following independent variables were identified and studied:
(i) concentration of PLGA used ranging from 0.1% to 0.4% w/v; (ii) concentration of PVA used ranging
from 4% to 7.5% w/v; (iii) concentration of prednisolone (API) to be incorporated in the nanoparticles
ranging from 0.5 to 2.0 mg/mL; (iv) homogenization time in minutes ranging between 10 and 20 min.
The composition of these batches is shown in Table 1.
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Table 1. Minitab batch composition. The four independent variables studied are; poly DL-lactic-
co-glycolic acid (PLGA), polyvinyl alcohol (PVA), amount of prednisolone (API) concentrations and
homogenization time (t); a partial factorial design with one center point was selected.
StdOrder RunOrder CenterPt Blocks PLGA% w/v
PVA
% w/v
API
mg/mL
t
(min)
Size Avg.
(n = 3)
Zeta Avg.
(n = 3)
1 1 1 1 0.1 4.0 0.5 10 751.2 ˘ 126.5 3.1 ˘ 0.1
2 2 1 1 0.4 4.0 0.5 10 710.6 ˘ 174.4 2.9 ˘ 0.4
9 3 1 1 0.1 4.0 0.5 20 678.2 ˘ 57.2 2.6 ˘ 0.8
8 4 1 1 0.4 7.5 2.0 10 556.7 ˘ 29.0 3.0 ˘ 0.3
3 5 1 1 0.1 7.5 0.5 10 768.3 ˘ 112.9 2.0 ˘ 0.5
11 6 1 1 0.1 7.5 0.5 20 671.9 ˘ 43.3 3.7 ˘ 0.2
10 7 1 1 0.4 4.0 0.5 20 668.4 ˘ 75.7 4.1 ˘ 1.3
12 8 1 1 0.4 7.5 0.5 20 555.9 ˘ 25.7 0.8 ˘ 0.2
7 9 1 1 0.1 7.5 2.0 10 743.7 ˘ 124.5 3.0 ˘ 0.3
6 10 1 1 0.4 4.0 2.0 10 708.9 ˘ 104.0 0.6 ˘ 0.6
16 11 1 1 0.4 7.5 2.0 20 538.8 ˘ 45.8 1.0 ˘ 0.2
15 12 1 1 0.1 7.5 2.0 20 818.3 ˘ 124.7 1.9 ˘ 0.1
14 13 1 1 0.4 4.0 2.0 20 653.5 ˘ 39.0 0.7 ˘ 0.1
4 14 1 1 0.4 7.5 0.5 10 734.3 ˘ 78.1 2.1 ˘ 0.3
5 15 1 1 0.1 4.0 2.0 10 640.2 ˘ 46.6 0.2 ˘ 0.3
13 16 1 1 0.1 4.0 2.0 20 692.1 ˘ 40.6 2.5 ˘ 0.3
2.4. Preparation of Prednisolone-Loaded Nanoparticles
Nanoparticles were prepared using the single emulsion-solvent evaporation method; the emulsion
prepared was oil-in-water (O/W). Prednisolone was dissolved along with the PLGA in DCM, while
PVA was dissolved in distilled water and was used in its aqueous phase [13,14].
The organic phase was slowly added to about one third of the aqueous phase while in a magnetic
stirrer then stirred at 2000 rpm for three hours and left overnight at a slow speed of 500 rpm in the
fume cupboard to allow evaporation of DCM. On the following day, the rest of the aqueous phase
(remaining two thirds) was added to the emulsion and stirred again at 2000 rpm for 1 h. The dispersion
was then sonicated in a water bath sonicator (Fisherbrand (FB-15049) sonicator, Fisher Scientific UK
Ltd., Loughborough, UK) for 15 min. Then the formed emulsion was homogenized using a Copley
homogenizer (model: Heidolph-DIAX 900, Sigma-Aldrich Company Ltd., Dorset, UK) at maximum
speed for 10–20 min. After homogenization, samples were withdrawn to determine the particle size
and the zeta potential of the formed nanoparticles. The samples were centrifuged using an ELMI
centrifuge (Model: CM-6MT, ELMI Ltd, Calabasas, CA, USA) at 3500 rpm at 4 ˝C, for 2 h and the
supernatant was collected to determine the drug-loading capacity of the nanoparticles.
2.5. Preparation of Nanoparticle-Laden Soft Contact Lenses
The NP-impregnated contact lenses were formulated once the results from the Minitab software
were analyzed and the nanoparticles were optimized accordingly. Contact lens matrix was prepared
with the following composition: HEMA (2-hydroxymethacrylate) (80%), MAA (methacrylic acid)
(19%) and EGDMA (ethylene glycol dimethacrylate) (1%). The three-polymeric mixture was stirred
until completely miscible. Specified amounts were then injected into casting molds to be thermally
polymerized at 80 ˝C.
2.6. Nanoparticle Characterization
The particle size distribution and the zeta potential of the produced nanoparticles were determined
using laser diffraction particle size analyzer (DLS; Malvern Instruments zetasizer Model: 3000 HSA,
Malvern Instruments Ltd, Malvern, UK). Samples were adequately diluted and analyzed at 25 ˝C and
at an angle of 90 ˝C and results were presented at mean values ˘ (SD), n = 3.
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2.6.1. Encapsulation Efficiency Measurement
HPLC method was used to determine the percentage (%) of drug encapsulation efficiency in the
prepared nanoparticles. First, the nanoparticles were centrifuged (ELMI Model: Skyline CM-6MT,
ELMI Ltd., Latvia), the supernatant was collected and filtered using syringe filters and analyzed with
HPLC; Equation (1) was used to calculate% prednisolone encapsulation efficiency.
Prednisolone encapsulation efficiency p%q “ ptotal amount of drug´ free amount of drugqptotal amount of drugq ˆ 100 (1)
2.6.2. Scanning Electron Microscopy (SEM)
Scanning electron microscope (SEM, Zeiss Evo50-Oxford instrument, Cambridge, UK) was used
to study the surface morphology of the formed prednisolone nanoparticles. Samples were prepared by
sprinkling prednisolone or adding a drop of nanoparticle suspension onto specimen stubs. After drying
the suspension, stubs were loaded onto a universal specimen holder. In order to enable electricity
conduction, samples were coated with a fine layer of gold using a sputter coater (Polaron SC500,
Polaron Equipment, Watford, UK) at 20 mA for three minutes at low vacuum and in the presence of
argon gas (Polaron Equipment, Watford, UK).
2.6.3. Thermal Analysis
Differential Scanning Calorimeter (Mettler Toledo instrument (Model: DSC822e-, Mettler-Toledo
Ltd., Leicester, UK) was used to characterize the solid state, polymorphism and phase behavior of
the API and nanoparticles. Approximately 2–3 mg of the sample was weighed and placed into an
aluminum sample pan (50 µL). An empty pan was used as a reference, both pans were covered with
the aluminum lid and a small hole was pierced. The sample was then heated to 250 ˝C at a constant
heating rate of 10 ˝C/min. Each sample was investigated in triplicates. The thermograms were
analyzed using STAReSW 10.00 software.
Thermogravimetric Analysis (TGA) was used (Mettler Toledo instrument, Model: TGA/DSC 1
STARe system, Mettler-Toledo Ltd., Leicester, UK). In this technique the changes in both the physical
and chemical properties of the API and prepared nanoparticle are measured as a function of increasing
temperature 25–300 ˝C with constant heating rate of 10 ˝C/min the decomposition pattern is observed.
2.6.4. Freeze-Drying (Lyophilization)
Prior to freeze-drying, the nanoparticle suspension was put in a round bottom flask and was
kept in dry ice for 12 h. The sample was freeze-dried so the water within the sample is removed by
sublimation and desorption under vacuum (´50 ˝C). Nanoparticles were lyophilized for 24 h using
a Telstar freeze dryer (Model: Cryodos, Dewsbury, West Yorkshire, UK).
2.7. Nanoparticle-Loaded Soft Contact Lens Characterization
2.7.1. Contact Lens Preparation
The hydrogels were prepared using 2-hydroxyethyl methacrylate (80%) (HEMA) as a backbone
monomer, methacrylic acid (19%) (MAA) as a functional polymer, ethylene glycol dimethacrylate (1%)
(EGDMA) as a cross-linker agent and finally prednisolone as the drug. The hydrogels were synthesized
by thermal polymerization at 80 ˝C for 4 h in polypropylene molds.
2.7.2. Contact Lens Hydration
Following polymerization, the formed lenses were subjected to hydration testing by soaking
in distilled water for 24 h at room temperature. Both dry and wet weights were recorded and the
results were presented as mean values ˘ (SD), n = 3. The equation below was used to calculate
the% hydration.
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Hydration p%q “ Lens wet weight – Lens dry weight
Lens wet weight
ˆ 100 (2)
2.7.3. Surface Contact Angle
Contact angle measurements were performed using KRUSS DSA30S, (KRÜSS GmbH, Borsteler
Chaussee, Germany). The contact angle was measured using the static sessile drop method, after
vertically dispensing droplets of deionized water of a specified volume (8 µL) onto the contact lens
surface; using a high-tech optical camera, the angle that was created between the baseline of the drop
(solid-liquid interface) and the tangent (liquid-air surface) was determined (Figure 1).
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Figure 1. Measurement of contact angle is purely dependent on a series of connections recognized
by Young (1805), where by the contact angle of a liquid drop on the solid surface is defined by the
mechanical equilibrium of the liquid drop under the process of three tensions. This is defined as
Young’s Equation (3).
σs “ Ysl ` σl ¨ cos θ (3)
According to Young, there is a connection between the contact angle θ, the surface free energy of
the solid σs, the interfacial tension between the liquid and the solid Ysl, and the surface tension of the
liquid σl.
2.7.4. Light Trans ission
The transparency of all contact lenses was easured using UV-spectrophoto eter at the
wavelength of 600 n [15]. The contact lenses were soaked in distilled water overnight making
them flexible to fit into the cuvette after which light transmission was measured.
2.7.5. exture nalysis
. T.plus Texture Analyser (Stable icrosyste s Ltd, S rrey, UK) as used to deter i e t e
el sti it te sil stre t of the contact lenses. l t i t s ecific
i i l t , width and thickness of th len es were 25, 15 and 2 mm, resp ctively.
The cut sample was then fit onto the texture analysis clamp and stretched until breaking point.
Young’s modulus w s calculated using the stress a d strain values obtai ed. Tensile strength f he
co tact len es was det rmined by using the maxi um force applied until the breakpoint s
) d (4) were used to calculate Young’s mod lus and tensile strength, respectively.
All measur ments were carried out in triplicate and pres nted as mean value ˘ stan ard deviation.
Young1s modulus “ Stress pMPaq
Strain p%q (4)
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Tensile strength “ Force pNq
Cross´ sectional area pmm2q (5)
2.7.6. Drug Release Study
An in vitro drug release study was carried out over 24 h using phosphate buffered saline (PBS) as
the release medium. The contact lenses were immersed in 10 mL of PBS and placed in a mechanical
shaking bath. The release of prednisolone from the NP alone was also detected by placing 0.4 g of
NP in a dialysis bag and placing this bag in a plastic tube containing 10 mL of PBS. This tube was
also placed together with the contact lenses in the shaker which was set at 80 cycles/min at 35.5 ˝C.
Aliquots of 0.5 mL were taken at set time-intervals (0.5, 1, 1.5, 3, 6 and 24 h) and replaced by equivalent
volumes of fresh PBS. Withdrawn samples were diluted with 2 mL of methanol, then run through
HPLC to quantify concentration of prednisolone released.
2.7.7. Statistical Analysis
All experiments were carried out in triplicate and the values were expressed as mean ˘ SD.
Statistical data analyses were conducted using Minitab® (Minitab, Inc, State college, PA, USA), one-way
analysis of variance (ANOVA) was used and data generated were statistically significant with p < 0.05.
3. Results
3.1. Design of Experiment (DoE)
Two-level full factorial design was used to optimize PLGA nanoparticulate systems. Four
independent variables (PLGA, PVA, API concentrations and homogenization time) were explored;
once 16 experiments were generated by Minitab, the nanoparticles were formulated and evaluated
based on three dependent variables (responses): particle size, encapsulation efficiency and surface
charge. The DoE was conducted to optimize the formulation of NP and assist in identifying optimal
conditions, namely; a small particle size (100–250 nm), maximum surface charge for higher stability
and maximum encapsulation efficiency. Minitab was used to generate plots demonstrating the effects
of each variable on the response.
3.2. The Effect of Different Parameters on Particle Size
Particle size has a drastic effect on the bioavailability of drugs delivered using nanoparticles.
Smaller particle size increases the surface area, hence the greater interaction with release medium;
better solubility and improved dissolution. Figure 2 describes the effect of formulation parameters
on particle size. Increasing the PLGA co-polymer concentration has the most predominant effect on
decreasing the particle size. The samples that contained the highest concentrations of PLGA have
resulted in the smallest nanoparticles, as shown by samples 4, 8 and 11. The amounts of PVA and
API have resulted in a decreased particle size but was not as significant as the effect of increasing
PLGA; increasing homogenization time also decreased particle size. Longer homogenization time
along with higher amount of API (such as those used such in sample 11) yielded the smallest size
of nanoparticles (538.8 nm). Many studies have demonstrated that both homogenization time and
speed significantly affect the size of the formed nanoparticles. Javadzadeh et al. (2010) prepared
PLGA nanoparticles loaded with naproxen; the study evaluated the effect of various homogenizing
speeds on the formation of nanoparticles. Particles with a size range between 352 and 571 nm were
formed; the smallest particle size was obtained by homogenizing at 20,000 rpm [16]. A more recent
study by Narayanan et al. (2014) investigated the effect of process variables on the preparation of
hyaluronidase-loaded PLGA nanoparticles. The effect of PLGA concentration, PVA concentration,
internal and external phase ratio, homogenization speed and time on the mean particle, and zeta
potential were studied. Results indicated that an increase in PVA concentration within external phase
preparation contributed to smaller particle size of <400 nm, zeta potential of <´30 mV; this was
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ascribed to the surfactant stabilizing effect in reducing the surface tension of the continuous phase.
Homogenization speed and time had maximum effect on reducing particle size [17,18].
Pharmaceutics 2016, 8, 14 8 of 16 
ascribed to the surfactant stabilizing effect in reducing the surface tension of the continuous phase. 
Homogenization speed and time had maximu  effect on re cing article size [17,18]. 
 
Figure 2. Main effects plot showing the effect of PLGA, PVA, prednisolone concentrations and 
homogenization time on the particle size of PLGA nanoparticles. 
3.3. The Effect of Formulation Parameters on Encapsulation Efficiency 
Drug encapsulation efficiency of the nanoparticles was determined using HPLC. Drug 
encapsulation efficiency (EE) values ranged between 60% and 92%. These relatively high values of 
EE could be attributed to the use of dichloromethane, which is a very good solvent for the polymers 
and the drug employed, where all components were dissolved in this solvent medium (Blanco et al., 
2011) [19]. Figure 3 reveals that the concentration of prednisolone is the determinant factor of the 
drug entrapment efficiency. Higher drug-loading into the nanoparticles was obtained with samples 
4, 9, 10, 11, 12, 13, 15 and 16, where the loading efficiency ranged between 85% and 95%. As shown in 
Figure 3 increasing the concentration of prednisolone (API) had the most significant effect in 
increasing the entrapment efficiency of the API in the formed nanoparticles, also increasing the 
amounts of PVA and PLGA had an effect on the entrapment efficiency but not as significant as the 
effect of API concentration; increasing homogenisaation time had a little or no effect on the 
entrapment efficiency. Improved entrapment efficiency may protect the API from enzymatic 
degradation, and could allow better API delivery to target site [19,20]. 
 
Figure 3. Main effects plot showing the effect of the four independent variables; PLGA, PVA, 
prednisolone concentrations and homogenization time on the drug loading into the nanoparticles. 
0.40.1
720
700
680
660
640
7.54.0
2.00.5
720
700
680
660
640
2010
PLGA
M
ea
n
PVA
API Homogen.
Main Effects Plot for particle size
Data Means
0.40.1
90
85
80
75
7.54.0
2.00.5
90
85
80
75
2010
PLGA
M
ea
n
PVA
API Homogen.
Main Effects Plot for drug load
Data Means
Figure 2. Main effects plot sho ing the effect of PL , PV , prednisolone concentrations and
homogenization time on the particle size of PL nano articles.
3.3. The Effect of Formulation Parameters on Enca s l ti ffi i c
Drug encapsulation efficiency of the nanoparticles as determined using HPLC. Drug
encapsulation efficiency (EE) values ranged between 60% and 92%. These relatively high values
of EE could be attributed to the use of dichloromethane, which is a very good solvent for the polymers
and the drug employed, where all components were dissolved in this solvent medium (Blanco et al.,
2011) [19]. Figure 3 reveals that the concentration of prednisolone is the determinant factor of the drug
entrapment efficiency. Higher drug-loading into the nanoparticles was obtained with samples 4, 9,
10, 11, 12, 13, 15 and 16, where the loading efficiency ranged between 85% and 95%. As shown in
Figure 3 increasing the concentration of prednisolone (API) had the most significant effect in increasing
the entrapment efficiency of the API in the formed nanoparticles, also increasing the amounts of
PVA and PLGA had an effect on the entrapment efficiency but not as significant as the effect of API
concentration; increasing homogenisaation time had a little or no effect on the entrapment efficiency.
Improved entrapment efficiency may protect the API from enzymatic degradation, and could allow
better API delivery to target site [19,20].
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3.4. The Effect of Different Parameters on Surface Charge of Nanoparticles
The values of the obtained surface charge ranged between 0.2 and 4 mV (Table 1, Figure 4). Low
values of zeta potential reflect the formation of neutral nanoparticles; surface charge or the electrical
charge properties control interactions between nanoparticles and therefore determine the overall
behavior and stability of the nanoparticles [21].
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3.5. Formulation Optimization
To achieve a particle size smaller than 500 m, high surface charge and maximum drug
entrapment efficiency, the following optimized conditions were identified by Minitab used:
0.4% (g/100 L) concentration of PLGA, 7.5% (g/100 mL) PVA, 2 mg/mL API (prednisolone), and
10 min of homogenization time.
3.6. Characterization of the Optimized Nanoparticle Preparation
The optimized prednisolone nanoparticles showed particle size of 294.5 ˘ 1.8 nm and surface
potential of 5.6 ˘ 1.8 mV.
The size and the surface morphology were elucidated using scanning electron microscope (SEM).
Figure 5A shows individual and aggregates of prednisolone-loaded PLGA nanoparticles with particle
size of around 300 nm. Aggregation could be attributed to the low surface charge carried by PLGA
nanoparticles as suggested by the zeta potential studies. The prepared nanoparticles were spherical in
shape with a smooth outer surface (Figure 5B).
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3.7. Thermal Analysis
Differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) can be used to
determine a number of characteristics such as physical and thermal properties by measuring the energy
transfer of API, characterize the matrix solid state, including polymorphism and phase behavior.
Figure 6 displays the DSC thermogram for the PLGA polymer, prednisolone and the prepared
nanoparticles. Prednisolone exhibited an endothermic peak displaying melting at 250 ˝C [22]. PLGA
had a major endothermic peak starting at around 342 ˝C that possibly could represent melting. The
melting endotherm suggests the presence of some crystalline regions in PLGA polymer [23]. PVA
showed a melting point at around 240 ˝C (Figure 6D) followed by a degradation at around 270 ˝C,
similar results were suggested by [24]. PLGA NPs showed an endothermic peak at 120 ˝C which could
be attributed to the evaporation of water that was used during the preparation of the nanoparticle.
Coupling the DSC with the TGA data confirm the suggestion as the weight of the nanoparticles dropped
by 11% as suggested by the TGA results. The second peak at 240 ˝C could be attributed to the presence
of some PVA residue in the prepared NPs. On the other hand, the formulated PLGA nanoparticle
did not show any major thermal events at 250 ˝C, suggesting a possible molecular dispersion of
prednisolone within the PLGA polymer matrix during the formation of the nanoparticulate system
(Figure 6B).
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by TGA, the midpoints were delayed and occurred at higher temperatures as the mass (3.4 mg) was 
lost gradually in three events. The first was at a midpoint of 71.6 °C where the mass loss of 11% 
could be attributed to the evaporation of any residual solvents; the second loss was at a midpoint of 
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Figure 7 displays combined graphs of the thermogravimetric analysis of the PLGA, prednisolone
and the prepared nanoparticles. PLGA by itself lost 98.7% of its mass by TGA in the endothermic event
observed between 177.74 and 450.4 ˝C and a midpoint of 372.18 ˝C. Prednisolone also lost its mass in
two events. First mass loss of 7.72% was between 209.5 and 313.57 ˝C with a midpoint of 291.21 ˝C.
The second event was a loss of 78.26% of the remaining mass between 315.7 and 601 ˝C at a midpoint
of 433.74 ˝C. When the prepared nanoparticles were tested by TGA, the midpoints were delayed and
occurred at higher temperatures as the mass (3.4 mg) was lost gradually in three events. The first was
at a midpoint of 71.6 ˝C where the mass loss of 11% could be attributed to the evaporation of any
residual solvents; the second loss was at a midpoint of 343.6 ˝C, where the mass loss of 50.6% was
similar to the midpoint of the prednisolone graph, proving that the API was successfully incorporated
in the preparation. The mass lost in the third event was at midpoint 453.7 ˝C and was equal to 26.6%
due to decomposition.
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3.8. Nanoparticle Incorporation into Contact Lenses (Preparation and Characterization)
The optimized nanoparticles were incorporated in the contact lens matrix made of 80% HEMA,
19% MAA as a functional polymer cross-linked by 1% EGDMA. The formulated soft contact lenses
were subjected to a number of characterization studies in order to understand their physical, optical
and mechanical properties.
3.8.1. Hydration and Surface Contact Angle
The ocular surface and anterior eye segment relies on the aqueous humor for nutrients and on
external supply of oxygen through the precorneal tear film and cornea. Hence, it is very essential
for ocular hydrogels or contact lenses to permit sufficient oxygen supply [25]. Good contact lens
hydration is required to allow efficient oxygen permeability [26]. If lens hydration is too low, then an
insufficient amount of oxygen would reach the cornea. This would lead to various conditions such as
acute and chronic hypoxia. However, very high water content could render the contact lens prone
to dehydration [27]. Extended wear of contact lenses could also cause discomfort to the eye as the
hydration decreases over time leaving the eyes dry [28]. It is therefore important that contact lenses
remain appropriately hydrated to avoid any future complications and discomfort for the users.
The average hydration for unloaded NP contact lenses was found to be 35.9% ˘ 0.4% (Figure 8).
Contact lenses with NP demonstrated a decrease in hydration compared with the unmodified (normal)
contact lenses as follows; 31.2% ˘ 1.3%; p = 0.01 (0.2 g NP) and 30.4% ˘ 0.7%; p = 0.0005 (0.4 g NP)
(Figure 9).
Figure 8 for hydration showed that there was a significant (p < 0.05) decrease of hydration with the
addition of the NP. The decreasing pattern maintained with the addition of more NP; 31.2% ˘ 1.25%
with 0.2 g NP (p = 0.01) and 30.4%˘ 0.67% with 0.4 g NP (p = 0.0005). Similar decrease of water content
with integration of NP was reported by Jung et al. (2012) [28], in which the authors reported a decrease
(from 73% to 33.27%–63.82%) in the presence of NPs in the hydrogels depending upon the amount
of NPs.
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Surface wettability is very crucial for contact lens comfort. Good wettability of contact lenses
helps maintain a normal and functional ocular surface. Poor surface wettability will increase lipid
deposition and promote protein denaturation. Contact lenses investigated in this study all had contact
angles below 90 ˝C which suggests good wettability (Figure 8). A lower contact angle was obtained
upon incorporation of NP (versus 85 ˝C with unmodified (normal) lenses, 73.3 ˝C (p = 0.04) and 80.7 ˝C
(p = 0.25) with the 0.2 g and 0.4 g NP-loaded contact lenses, respectively) (Figure 8).
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Figure 9. Light transmission through contact lenses at visible wavelength of 600 nm. Data are presented
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The degrees of wetta ility of contact lenses are established based on the adhesi nd cohesive
forces. For lenses to be comfortable and devoid of eye dryness effect they must have a good wettability.
The human eyes blink very frequently 12 blinks a minute on average, and with every blink, the tear film
spreads over the ocular surface and helps to maintain hydration. Contact lenses with good wettability
will not impair the precorneal tear film spreading onto the ocular surface [28]. The improved wettability
Pharmaceutics 2016, 8, 14 13 of 16
of the NP-loaded contact lenses could be due to the contribution of the hydrophilic monomers (HEMA
and MAA). It was seen that the addition of NP significantly lowered the contact angle.
3.8.2. Light Transmission
Ideally, a soft contact lens should have light transmittance of above 90%; however some of the
reported values in the literature for p-HEMA by itself was 87% [23]. Incorporation of nanoparticulate
systems can drop the transparency of the contact lenses significantly as the nanosized particles diffract
and scatter the incident lights. Gulsen et al. reported that incorporating microemulsions into p-HEMA
contact lenses dropped light transmittance to 79%, 69% and even 4.4 and 19% [23].
The unloaded NP contact lenses prepared using the mixture of HEMA and MAA were all clear
and transparent; their light transmission measured at 600 nm showed high transmission of 94.5%
(Figure 9). The incorporation of NP did lower the transmission to 86.23% and 83.1% for the 0.2 g and
0.4 g NPs, respectively (Figure 9). It was observed that the increase in NP concentration gradually
decreased the transmission. Therefore, it was necessary to add the appropriate amount of NP to
avoid lack of transparency, which in turn would affect vision. These observations were comparable
to previous studies which tested microemulsion-loaded hydrogels [29]. The results obtained here
supported the use of NP in contact lenses without compromising the visibility. The study suggested
that there was low or no opacity. The use of the contact lenses with suitable amount of NP would not
affect the vision of the wearer which is essential. Compromised vision when using the contact lenses
would result in poor compliance.
3.9. Mechanical Characterization
3.9.1. Young’s Modulus
Contact lenses must possess good mechanical characteristics; otherwise they could be prone
to damage during handling and insertion within the eye, and could be uncomfortable to wear [30].
The elasticity—given by the Young’s modulus—showed minimal changes to all of the lenses. A high
proportion of hydrophilic monomers increase the water content. However, high water content can
result in a weak mechanical strength of the material [30]. Therefore, a combination of HEMA and
MAA was used to boost the hydrophilicity and also maintain mechanical strength. Low tensile
strength and modulus for the contact lenses were observed and this could be attributed to the use
of the hydrophilic copolymers. It should be noted that the stiffness of the lenses increases with the
modulus of elasticity [30]. Hence, it can be said that the contact lenses formulated which demonstrated
small Young’s modulus values only suggests a soft flexible material therefore more comfortable for
long wear.
Young’s modulus for NCL was 0.0163 ˘ 0.002 MPa. The addition of NP resulted in slight but
non-significant decrease in the Young’s modulus. The average value for 0.2 g NP was 0.0156 ˘ 0.001
MPa (p = 0.314) and for 0.4 g NP was 0.0135 ˘ 0.003 MPa (p = 0.121) (Figure 10).
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3.9.2. Tensile Strength
The contact lenses were subjected to maximum load or stretched until a breaking point, i.e. the
maximum force needed to achieve this breakpoint. This value—force at breakpoint—together with the
cross-sectional areas of the contact lenses were used to calculate the tensile strength.
The tensile strength for NCL was calculated to be 0.0584 ˘ 0.01 Nmm´2 (Figure 11). The values
did not change significantly with the addition of nanoparticles in the contact lenses (0.0678 Nmm´2;
p = 0.137 for 0.2 g NP vs. 0.0591 Nmm´2; p = 0.470 for 0.4 g NP). These findings suggest that the contact
lenses can maintain their elasticity even upon incorporation of 0.4 g of NP, thus corroborating the
suggestion in a previous study by Tranoudis et al [28] of establishing a positive correlation between the
elasticity and tensile strength.
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3.9.3. Drug Release Study
In vitro release of prednisolone from the NP-loaded contact lenses and NP on their own showed
a two-phase process. An initial burst release was seen for both samples. This was then followed by
a slower release process (Figure 12).
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nanoparticles over 24 h.
The drug release study was carried out over 24 h using 10 mL of PBS as the release media [22].
The contact lenses containing 0.4 g NP and the NP alone were subjected to this test. The total drug
release over 24 h from NP and NP-loaded contact lenses were 42.3% and 10.8%, respectively. This could
Pharmaceutics 2016, 8, 14 15 of 16
be ascribed to the fact that the drug needed to diffuse from both inside the NP and then the contact
lenses matrix in case of NP-loaded contact lenses delaying the release. The initial release could be due
to the entrapped drug attaching to the surface. The slow release is most likely to be associated with
drug entrapped in NP [23]. For the drug to be released into the tear fluid and onto the ocular surface,
it needs to diffuse through the polymeric matrix of the NP. PVA could also form a barrier due to its
swelling ability which again contributed to a slower release [9].
It has been reported that ocular drugs marketed as eye drops have fast drug release whereby
nearly all of the drugs were released within few hours [9]. The incorporation of drugs in NP
extended the delivery by hours or even days [24]. A study by Gupta et al. tested the drug release of
a commercially available formulation of sparfloxacin (an antibiotic) with PLGA-NP containing the
same drug. The results showed that the commercial formulation released almost all drugs within 6 h,
whereas the NP released about 85.8% drug in 24 h [9]. The data obtained in this work supported these
findings regarding sustained release by maintaining a slow drug release.
4. Conclusions
According to the data generated by the Minitab software, the parameter with the greatest
impact in nanoparticle size was the amount of co-polymer (PLGA) used. Increasing the
concentration of prednisolone (API) had the most significant effect in increasing entrapment efficiency
within the nanoparticle formulation. Also, the homogenization time had minimal effect on the
entrapment efficiency. The optimized prednisolone nanoparticle obtained displayed a particle size of
294.5 ˘ 1.8 nm with surface charge of 5.6 ˘ 1.8 nm. The NP-loaded contact lenses were then compared
to unloaded NP contact lenses. Unloaded contact lenses had a slightly better hydration of 2% difference
when compared to nanoparticle-loaded contact lenses. All contact lenses showed good surface
wettability. Increase in NP concentration gradually decreased the transmission by 8% when compared
to unloaded contact lenses. Drug release studies over 24 h showed that nanoparticle-incorporated
contact lenses displayed a slow and prolonged drug release.
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